Brief: Mineralys Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
Mineralys Therapeutics Inc MLYS.O :
* MINERALYS THERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* MINERALYS THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.51
Source text for Eikon: ID:nGNX2Pb2pj
Further company coverage: MLYS.O
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway